• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见胃肠道疾病中肠屏障功能障碍的临床相关性

Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases.

作者信息

Muehler Andreas, Slizgi Jason R, Kohlhof Hella, Groeppel Manfred, Peelen Evelyn, Vitt Daniel

机构信息

Immunic, AG, Gräfelfing 82166, Germany.

出版信息

World J Gastrointest Pathophysiol. 2020 Dec 12;11(6):114-130. doi: 10.4291/wjgp.v11.i6.114.

DOI:10.4291/wjgp.v11.i6.114
PMID:33362939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7739114/
Abstract

The intestinal barrier is a complex and well-controlled physiological construct designed to separate luminal contents from the bowel wall. In this review, we focus on the intestinal barrier's relationship with the host's immune system interaction and the external environment, specifically the microbiome. The bowel allows the host to obtain nutrients vital to survival while protecting itself from harmful pathogens, luminal antigens, or other pro-inflammatory factors. Control over barrier function and the luminal milieu is maintained at the biochemical, cellular, and immunological level. However, disruption to this highly regulated environment can cause disease. Recent advances to the field have progressed the mechanistic understanding of compromised intestinal barrier function in the context of gastrointestinal pathology. There are numerous examples where bowel barrier dysfunction and the resulting interaction between the microbiome and the immune system has disease-triggering consequences. The purpose of this review is to summarize the clinical relevance of intestinal barrier dysfunction in common gastrointestinal and related diseases. This may help highlight the importance of restoring barrier function as a therapeutic mechanism of action in gastrointestinal pathology.

摘要

肠道屏障是一种复杂且受严格调控的生理结构,旨在将肠腔内容物与肠壁分隔开来。在本综述中,我们重点关注肠道屏障与宿主免疫系统相互作用以及外部环境(特别是微生物群)之间的关系。肠道使宿主能够获取对生存至关重要的营养物质,同时保护自身免受有害病原体、肠腔抗原或其他促炎因子的侵害。在生化、细胞和免疫水平上维持对屏障功能和肠腔环境的控制。然而,这种高度调节的环境受到破坏会导致疾病。该领域的最新进展加深了对胃肠道病理学背景下肠道屏障功能受损机制的理解。有许多例子表明,肠道屏障功能障碍以及由此导致的微生物群与免疫系统之间的相互作用会引发疾病。本综述的目的是总结肠道屏障功能障碍在常见胃肠道及相关疾病中的临床相关性。这可能有助于凸显恢复屏障功能作为胃肠道病理学治疗作用机制的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7739114/c5fdf68d4ff2/WJGP-11-114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7739114/c5fdf68d4ff2/WJGP-11-114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7739114/c5fdf68d4ff2/WJGP-11-114-g001.jpg

相似文献

1
Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases.常见胃肠道疾病中肠屏障功能障碍的临床相关性
World J Gastrointest Pathophysiol. 2020 Dec 12;11(6):114-130. doi: 10.4291/wjgp.v11.i6.114.
2
The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.性与应激对脑-肠-微生物群轴及肠道屏障稳态的联合调节作用:对肠易激综合征的影响
Neurogastroenterol Motil. 2016 Apr;28(4):463-86. doi: 10.1111/nmo.12717. Epub 2015 Nov 11.
3
Roles of gastrointestinal polypeptides in intestinal barrier regulation.胃肠道多肽在肠道屏障调节中的作用。
Peptides. 2022 May;151:170753. doi: 10.1016/j.peptides.2022.170753. Epub 2022 Jan 31.
4
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
5
Microbial-gut interactions in health and disease. Mucosal immune responses.健康与疾病中的微生物-肠道相互作用。黏膜免疫反应。
Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):387-404. doi: 10.1016/j.bpg.2003.11.002.
6
Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.肠道病原体及其毒素通过改变鸡的紧密连接对肠道屏障造成的破坏
Toxins (Basel). 2017 Feb 10;9(2):60. doi: 10.3390/toxins9020060.
7
Intestinal barrier dysfunction in inflammatory bowel diseases.炎症性肠病中的肠道屏障功能障碍
Inflamm Bowel Dis. 2009 Jan;15(1):100-13. doi: 10.1002/ibd.20539.
8
Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.炎症性肠病的细胞和分子治疗靶点-聚焦于肠道屏障功能。
Cells. 2019 Feb 22;8(2):193. doi: 10.3390/cells8020193.
9
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.多发性硬化症的肠道屏障:对病理生理学和治疗的影响。
Brain. 2018 Jul 1;141(7):1900-1916. doi: 10.1093/brain/awy131.
10
Intestinal Permeability, Inflammation and the Role of Nutrients.肠道通透性、炎症与营养素的作用。
Nutrients. 2020 Apr 23;12(4):1185. doi: 10.3390/nu12041185.

引用本文的文献

1
Epigenetic modulation of the NLRP6 inflammasome sensor as a therapeutic modality to reduce necroptosis-driven gastrointestinal mucosal dysfunction in HIV/SIV infection.作为一种治疗方式,对NLRP6炎性小体传感器进行表观遗传调控,以减轻HIV/SIV感染中坏死性凋亡驱动的胃肠道黏膜功能障碍。
Cell Commun Signal. 2025 Apr 25;23(1):199. doi: 10.1186/s12964-025-02193-0.
2
Celiac Disease: Beyond Diet and Food Awareness.乳糜泻:超越饮食与食物认知
Foods. 2025 Jan 24;14(3):377. doi: 10.3390/foods14030377.
3
Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity.

本文引用的文献

1
Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study.炎症性肠病与更高的痴呆风险相关:一项全国性纵向研究。
Gut. 2021 Jan;70(1):85-91. doi: 10.1136/gutjnl-2020-320789. Epub 2020 Jun 23.
2
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.针对 zonulin 和肠道上皮屏障功能以预防关节炎的发生。
Nat Commun. 2020 Apr 24;11(1):1995. doi: 10.1038/s41467-020-15831-7.
3
Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
体重指数增加在肥胖症患者肠道屏障功能障碍、全身炎症和代谢失调中的作用
Nutrients. 2024 Dec 28;17(1):72. doi: 10.3390/nu17010072.
4
The Effects of a Very-Low-Calorie Ketogenic Diet on the Intestinal Barrier Integrity and Function in Patients with Obesity: A Pilot Study.极低热量生酮饮食对肥胖患者肠屏障完整性和功能的影响:一项初步研究。
Nutrients. 2023 May 30;15(11):2561. doi: 10.3390/nu15112561.
5
Analysis of Intestinal Metabolites in SR-B1 Knockout Mice via Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry.基于超高效液相色谱-四极杆飞行时间质谱联用技术分析载脂蛋白 B 受体 1 基因敲除小鼠的肠道代谢产物。
Molecules. 2023 Jan 6;28(2):610. doi: 10.3390/molecules28020610.
6
How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections.我们对肠道屏障功能障碍在复发性尿路感染发病机制中的作用了解到何种程度?
Front Pharmacol. 2022 Mar 10;13:780122. doi: 10.3389/fphar.2022.780122. eCollection 2022.
7
Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats.化疗药物联合肠腔刺激物对大鼠小肠甘露醇通透性和绒毛长度的影响。
Int J Mol Sci. 2022 Jan 18;23(3):1021. doi: 10.3390/ijms23031021.
8
Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases.干扰素λ在炎症性肠病发病机制中的作用。
Front Immunol. 2021 Oct 12;12:767505. doi: 10.3389/fimmu.2021.767505. eCollection 2021.
9
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.《交战规则:上皮-微生物相互作用与炎症性肠病》
Front Med (Lausanne). 2021 Aug 27;8:669913. doi: 10.3389/fmed.2021.669913. eCollection 2021.
克罗恩病患者黏膜愈合后持续腹泻与肠道微生物组多样性降低和菌群失调增加有关。
Clin Gastroenterol Hepatol. 2021 Feb;19(2):296-304.e3. doi: 10.1016/j.cgh.2020.03.044. Epub 2020 Mar 24.
4
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease.免疫检查点抑制剂治疗伴有既往炎症性肠病的患者。
J Clin Oncol. 2020 Feb 20;38(6):576-583. doi: 10.1200/JCO.19.01674. Epub 2019 Dec 4.
5
Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征肠道黏膜的超微结构
Physiol Int. 2019 Sep 1;106(3):225-235. doi: 10.1556/2060.106.2019.20. Epub 2019 Sep 27.
6
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease.炎症性肠病的当前和新型治疗方法的观点。
Gut Liver. 2019 Nov 15;13(6):604-616. doi: 10.5009/gnl19019.
7
Intestinal Permeability Measured by Urinary Sucrose Excretion Correlates with Serum Zonulin and Faecal Calprotectin Concentrations in UC Patients in Remission.通过尿蔗糖排泄量测定的肠道通透性与缓解期UC患者的血清连蛋白和粪便钙卫蛋白浓度相关。
J Nutr Metab. 2019 Apr 1;2019:2472754. doi: 10.1155/2019/2472754. eCollection 2019.
8
Mechanisms regulating intestinal barrier integrity and its pathological implications.调节肠道屏障完整性的机制及其病理意义。
Exp Mol Med. 2018 Aug 16;50(8):1-9. doi: 10.1038/s12276-018-0126-x.
9
Anti-TNF Therapy in Crohn's Disease.抗 TNF 治疗克罗恩病。
Int J Mol Sci. 2018 Jul 31;19(8):2244. doi: 10.3390/ijms19082244.
10
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.免疫检查点抑制剂的胃肠道毒性:从机制到管理。
Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):222-234. doi: 10.1038/nrgastro.2018.14. Epub 2018 Mar 7.